ask="17.00"
ask_size="100"
average_daily_volume="167235"
bid="4.15"
bid_size="100"
book_value="7.07"
change="+0.46"
change_from_200_day_moving_average="6.81"
change_from_50_day_moving_average="1.37"
change_from_52_week_high="0.00"
change_From_52_week_low="8.96"
change_in_percent="+4.73%"
close="10.18"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="10.18"
high_52_weeks="10.18"
last_trade_date="2/3/2017"
last_trade_price="10.18"
last_trade_size="200"
last_trade_time="4:00pm"
low="9.69"
low_52_weeks="1.22"
market_capitalization="107.55M"
moving_average_200_day="3.37"
moving_average_50_day="8.81"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.62"
open="9.70"
pe_ratio="N/A"
peg_ratio="0.14"
percent_change_from_200_day_moving_average="+202.01%"
percent_change_from_50_day_moving_average="+15.51%"
percent_change_from_52_week_high="+0.00%"
percent_change_from_52_week_low="+734.43%"
previous_close="9.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.38"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="13.10"
stock_exchange="NMS"
symbol="NVLN"
volume="71031"
weeks_range_52="1.22 - 10.18"
